Basic Information | Post buying leads | Suppliers |
Name |
5-Methyl-2-thioxo-4-imidazolidinone |
EINECS | N/A |
CAS No. | 33368-94-4 | Density | 1.37 g/cm3 |
PSA | 83.75000 | LogP | -0.49800 |
Solubility | N/A | Melting Point |
N/A |
Formula | C4H6N2OS | Boiling Point | N/A |
Molecular Weight | 130.17 | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Hydantoin,5-methyl-2-thio- (6CI,7CI,8CI);5-Methyl-2-thiohydantoin;5-methyl-2-thioxoimidazolidin-4-one;4-imidazolidinone, 5-methyl-2-thioxo-;5-Methyl-2-thioguidanthion;Hydantoin, 5-methyl-2-thio-;5-methyl-2-sulfanylideneimidazolidin-4-one; |
The 5-Methyl-2-thioxo-4-imidazolidinone, with the CAS registry number 33368-94-4, has the systematic name of 5-methyl-2-thioxoimidazolidin-4-one. It belongs to the product category of Thiol. And the molecular formula of the chemical is C4H6N2OS.
The characteristics of 5-Methyl-2-thioxo-4-imidazolidinone are as followings: (1)ACD/LogP: -0.12; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.12; (4)ACD/LogD (pH 7.4): -0.14; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 20.4; (8)ACD/KOC (pH 7.4): 19.7; (9)#H bond acceptors: 3; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 0; (12)Polar Surface Area: 55.64 Å2; (13)Index of Refraction: 1.614; (14)Molar Refractivity: 33.02 cm3; (15)Molar Volume: 94.7 cm3; (16)Polarizability: 13.09×10-24cm3; (17)Surface Tension: 62.9 dyne/cm; (18)Density: 1.37 g/cm3.
Addtionally, the following datas could be converted into the molecular structure:
(1)SMILES: O=C1NC(=S)NC1C
(2)InChI: InChI=1/C4H6N2OS/c1-2-3(7)6-4(8)5-2/h2H,1H3,(H2,5,6,7,8)
(3)InChIKey: HYDZMARBTYAIMU-UHFFFAOYAH
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | oral | 420mg/kg (420mg/kg) | Farmatsevtichnii Zhurnal Vol. 17(1), Pg. 36, 1962. | |
rat | LD50 | oral | 1050mg/kg (1050mg/kg) | British Journal of Pharmacology and Chemotherapy. Vol. 13, Pg. 350, 1958. |